Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells.
about
Osteoimmunology: interactions of the bone and immune systemA novel member of the leukocyte receptor complex regulates osteoclast differentiationBone loss. Factors that regulate osteoclast differentiation: an update.Bone loss. Therapeutic approaches for preventing bone loss in inflammatory arthritisOsteoporosis, inflammation and ageingA review of UHMWPE wear-induced osteolysis: the role for early detection of the immune response.Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclastsHIV: inflammation and boneFunctional Local Renin-Angiotensin System in Human and Rat Periodontal TissueFunctional role for heat shock factors in the transcriptional regulation of human RANK ligand gene expression in stromal/osteoblast cellsEstrogen regulation of immune cell bone interactionsMutational analysis of sclerostin shows importance of the flexible loop and the cystine-knot for Wnt-signaling inhibitionRANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapiesInterleukin-6 deficiency increases inflammatory bone destructionNF-Y is essential for the recruitment of RNA polymerase II and inducible transcription of several CCAAT box-containing genesRegulation of osteoclast differentiationThe anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis.Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation.Areca nut extracts modulated expression of alkaline phosphatase and receptor activator of nuclear factor kappaB ligand in osteoblasts.Bone remodelling markers in rheumatoid arthritis.Gamma interferon positively modulates Actinobacillus actinomycetemcomitans-specific RANKL+ CD4+ Th-cell-mediated alveolar bone destruction in vivo.Osteoblast Role in Rheumatic Diseases.Osteoporosis in inflammatory bowel diseaseMultiple myeloma mesenchymal stromal cells: Contribution to myeloma bone disease and therapeuticsOsteoclasts and odontoclasts: signaling pathways to development and disease.The immune system and bone.Modulation of Wnt5a expression by periodontopathic bacteriaInvolvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption.Regulation of bone cell development and function: implication for renal osteodystrophy.Biology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond.Pro-inflammatory cytokines and bone fractures in CKD patients. An exploratory single centre study.Prevention of bone growth defects, increased bone resorption and marrow adiposity with folinic acid in rats receiving long-term methotrexate.Estrogen deficiency and bone loss: an inflammatory tale.Tumor necrosis factor-α signaling in macrophages.Role of RANK ligand in mediating increased bone resorption in early postmenopausal womenRole of RANKL and RANK in bone loss and arthritis.Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection.t10c12-CLA maintains higher bone mineral density during aging by modulating osteoclastogenesis and bone marrow adiposity.Do γδ T cells predict osteonecrosis of the jaw?Associated bone mineral density and obstructive sleep apnea in chronic obstructive pulmonary disease
P2860
Q24655113-ADC0F94D-9EAB-48EF-ACD4-06ABDD8D9031Q24675157-AF460C66-B016-4190-ABC2-B53EBEB006C9Q24805142-BB129A34-31CC-43FE-B610-6D1FC1625673Q24805600-63A9AFF2-52DC-4AD7-B48B-698B150DA23CQ24815520-CD5B7314-1CF2-4B2A-B781-455EC8351181Q26741081-F2E003FE-80C6-47E9-907E-FD3D71B0CD31Q26828486-5EDBB6B6-5C08-459E-BAC4-2A396892DE67Q27010898-41C59000-FB44-40CC-8B91-D9941A06EBDAQ27301201-CE8D7C07-99B8-467B-B03F-C4EDC546C357Q28236662-A4C9F167-4D59-40A9-9A60-FB6EA45F9D24Q28251201-6E01634A-4717-4D41-B693-E1E9424548FFQ28535490-187092E8-F2B9-43AC-A014-F6805CD430B6Q28570898-02E8983F-FDCC-4F3E-8FC5-84ADE3C79B89Q28587986-00E0F8C6-6C31-403B-802B-CFF3560995F7Q28590656-792C4457-3137-4AC5-840F-767D978BDEFEQ28593319-9C0EA43B-AE00-4C4C-B070-F56791690C34Q31132502-98F9126F-3114-415E-9FF0-5C126E07B68BQ31717820-55F337FA-88CC-49DE-B455-042E04EA6411Q33213751-F30E6C1F-8272-4C6E-BA59-09CF9B41AD69Q33563068-73FA8DFD-B41E-4C51-BC9A-E096340BBC41Q33788192-BDAE0744-9739-4EFF-86BE-728F7D2D7502Q33838967-986C4B44-20A2-41FB-8177-9CA32F570782Q33951441-C15EBCCB-F0F6-4855-803C-15639EA134F0Q34038854-9AB09928-CC30-4BB0-BCED-6CFA02F70054Q34127948-872733F5-2769-498D-B436-A75E69E32918Q34143343-2B66B31B-1CC6-4F8F-AEA4-7F2A2313B152Q34224898-A0EA3348-5EC2-447F-B624-E60976B46BBBQ34246960-A77A7F09-BABF-4060-95C2-C613D97622EDQ34250588-6A25EDDB-664F-4FDC-8AFF-8561B488A281Q34366449-5C0E0A1D-BAAC-44CA-B810-481B98BC12F5Q34435887-DB0A7A5E-4BEC-46B2-ABE7-E8A65CBF6361Q34447588-EBE82B56-4561-4B53-9C33-6FAF6210C5F2Q34576622-C4273C25-0D36-4AD5-9018-6CE15EBFF274Q34734335-6A0EAE4E-BE5D-4D3F-B5B4-6AB4ED5E7485Q34912769-FE90C060-BD28-4663-8AF6-B34CEDC9FD1FQ34963016-9EF8958D-FBA5-426C-A2CD-25BC0F819091Q35008871-77F7C88A-8E35-43A3-A4EC-55BF027C5926Q35012521-3BFF9F21-0823-4D84-9D1D-B211BBC46255Q35046087-45D865B1-4B6E-4906-A570-B3DF05038D43Q35063766-0B6916A1-F3B9-4F7F-A06E-D6671159456B
P2860
Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Interleukin-1beta and tumor ne ...... n in human osteoblastic cells.
@en
type
label
Interleukin-1beta and tumor ne ...... n in human osteoblastic cells.
@en
prefLabel
Interleukin-1beta and tumor ne ...... n in human osteoblastic cells.
@en
P2093
P1433
P1476
Interleukin-1beta and tumor ne ...... n in human osteoblastic cells.
@en
P2093
P304
P356
10.1016/S8756-3282(99)00162-3
P577
1999-09-01T00:00:00Z